NBTX
Desconocido
NOBEL: Mobilising the European nano biomedical ecosystem
NANOBIOTIX SA
participó en un
H2020:
H2020-NMBP-2016-2017
In order to compete globally, Europe has to innovate and develop nanomedicines and medical technologies with high value and high technologic...
2017-07-07 - 2020-12-31 | Financiado
2017-07-07 - 2020-12-31 | Financiado
ENATRANS: Enabling NAnomedicine TRANSlation
NANOBIOTIX SA
participó en un
H2020:
H2020-NMP-2014-2015
ENATRANS’ main objective is to network and support SMEs in translation of nanomedicine in Europe by providing a one-stop-shop service to int...
2014-12-10 - 2017-12-31 | Financiado
2014-12-10 - 2017-12-31 | Financiado
SONODRUGS: Image controlled Ultrasound induced Drug Delivery
NANOBIOTIX SA
participó en un
FP7:
The demographic changes in Europe towards an aging society will coincide with increasing morbidity of the population. European citizens need...
Financiado
Financiado
NANOMED2020: Enabling the European Nanomedicine Area until 2020
NANOBIOTIX SA
participó en un
FP7:
Nanotechnology applied to medical applications, Nanomedicine, is one of the most important emerging areas of health research and is understo...
Financiado
Financiado
* No se disponen de datos de la empresa actual.